Product Code: GVR-4-68040-352-9
Market Size & Trends
The global biocompatible 3D printing materials market size was estimated at USD 590.6 million in 2023 and is projected to grow at a CAGR of 14.3% from 2024 to 2030. Advancements in 3D printing techniques, including developing specialized biocompatible materials, enable the creation of patient-specific devices with enhanced functionality and improved integration with the human body. For instance, in August 2023, Materialise got involved in developing customized implants and surgical guides using biocompatible materials through its advanced 3D printing technologies. Their contributions highlight how personalized medicine drives the adoption of biocompatible 3D printing materials in various healthcare applications.
There is an increasing demand in the healthcare industry for biocompatible materials for various medical applications, such as implants, prosthetics, and tissue engineering. These materials are compatible with the human body to minimize the risk of rejection or adverse reactions, driving the need for advanced biocompatible 3D printing materials.
Technological advancements in 3D printing include significantly driven the market. The development of new materials and processes has enabled the creation of biocompatible materials that are safe for use in medical applications such as implants, prosthetics, and tissue engineering. For instance, CELLINK, a leading bio printing company, has developed bioinks that mimic human tissues' properties for more accurate and reliable tissue engineering applications.
The growing adoption of personalized medicine has significantly driven the biocompatible 3D printing materials market. Personalized medicine aims to provide tailored medical treatment to patients based on their unique genetic makeup, lifestyle, and other factors. In the context of 3D printing, this approach allows for the creation of customized medical devices, implants, and pharmaceuticals specifically designed to meet the needs of each patient.
Global Biocompatible 3D Printing Materials Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global biocompatible 3D Printing Materials market report on the basis of type, application, and region
- Type Outlook (Revenue, USD Million, 2018 - 2030)
- Polymer
- Metal
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Implants & Prosthesis
- Prototyping & Surgical Guides
- Tissue Engineering
- Hearing Aids
- Others
- Regional Outlook (Revenue in USD Million, 2018 - 2030)
- North America
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline.
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Biocompatible 3D Printing Materials Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing demand of biocompatible 3D printing materials in healthcare industry
- 3.2.1.2. Technological advancements in 3D printing materials
- 3.2.1.3. Growing adoption of personalized medicine
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost associated with the materials
- 3.3. Biocompatible 3D Printing Materials Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.2. PESTEL Analysis
Chapter 4. Biocompatible 3D Printing Materials Market: Type Estimates & Trend Analysis
- 4.1. Type Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Biocompatible 3D Printing Materials Market by Type Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Polymer
- 4.4.1.1. Polymer market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Metal
- 4.4.2.1. Metal market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Others
- 4.4.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Biocompatible 3D Printing Materials Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Biocompatible 3D Printing Materials Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Implants & Prosthesis
- 5.4.1.1. Implants & Prosthesis market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Prototyping & surgical guides
- 5.4.2.1. Prototyping & surgical guides market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Tissue Engineering
- 5.4.3.1. Tissue Engineering market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Hearing Aids
- 5.4.4.1. Hearing Aids market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Others
- 5.4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Biocompatible 3D Printing Materials Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2023 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.5. North America
- 6.5.1. North America
- 6.5.2. U.S.
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework
- 6.5.2.3. Competitive scenario
- 6.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. Canada
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework
- 6.5.3.3. Competitive scenario
- 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.4. Mexico
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework
- 6.5.4.3. Competitive scenario
- 6.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Europe
- 6.6.1. Europe
- 6.6.2. UK
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ Reimbursement
- 6.6.2.3. Competitive scenario
- 6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.3. Germany
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework/ Reimbursement
- 6.6.3.3. Competitive scenario
- 6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.4. France
- 6.6.4.1. Key country dynamics
- 6.6.4.2. Regulatory framework/ Reimbursement
- 6.6.4.3. Competitive scenario
- 6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.5. Italy
- 6.6.5.1. Key country dynamics
- 6.6.5.2. Regulatory framework/ Reimbursement
- 6.6.5.3. Competitive scenario
- 6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.6. Spain
- 6.6.6.1. Key country dynamics
- 6.6.6.2. Regulatory framework
- 6.6.6.3. Competitive scenario
- 6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.7. Denmark
- 6.6.7.1. Key country dynamics
- 6.6.7.2. Regulatory framework/ Reimbursement
- 6.6.7.3. Competitive scenario
- 6.6.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.8. Sweden
- 6.6.8.1. Key country dynamics
- 6.6.8.2. Regulatory framework
- 6.6.8.3. Competitive scenario
- 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.9. Norway
- 6.6.9.1. Key country dynamics
- 6.6.9.2. Regulatory framework
- 6.6.9.3. Competitive scenario
- 6.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Asia Pacific
- 6.7.2. Japan
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ Reimbursement
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. China
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ Reimbursement
- 6.7.3.3. Competitive scenario
- 6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. India
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ Reimbursement
- 6.7.4.3. Competitive scenario
- 6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.5. Australia
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework/ Reimbursement
- 6.7.5.3. Competitive scenario
- 6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.6. South Korea
- 6.7.6.1. Key country dynamics
- 6.7.6.2. Regulatory framework/ Reimbursement
- 6.7.6.3. Competitive scenario
- 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.7. Thailand
- 6.7.7.1. Key country dynamics
- 6.7.7.2. Regulatory framework/ Reimbursement
- 6.7.7.3. Competitive scenario
- 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Latin America
- 6.8.1. Latin America
- 6.8.2. Brazil
- 6.8.2.1. Key country dynamics
- 6.8.2.2. Regulatory framework
- 6.8.2.3. Competitive scenario
- 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8.3. Argentina
- 6.8.3.1. Key country dynamics
- 6.8.3.2. Regulatory framework/ Reimbursement
- 6.8.3.3. Competitive scenario
- 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9. MEA
- 6.9.1. MEA
- 6.9.2. South Africa
- 6.9.2.1. Key country dynamics
- 6.9.2.2. Regulatory framework/ Reimbursement
- 6.9.2.3. Competitive scenario
- 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.3. Saudi Arabia
- 6.9.3.1. Key country dynamics
- 6.9.3.2. Regulatory framework/ Reimbursement
- 6.9.3.3. Competitive scenario
- 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.4. UAE
- 6.9.4.1. Key country dynamics
- 6.9.4.2. Regulatory framework/ Reimbursement
- 6.9.4.3. Competitive scenario
- 6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.5. Kuwait
- 6.9.5.1. Key country dynamics
- 6.9.5.2. Regulatory framework
- 6.9.5.3. Competitive scenario
- 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2023
- 7.3.4. Formlabs Inc.
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Others benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. 3D Systems Inc.
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Others benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Evonik Industries AG
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Others benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Stratasys
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Others benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Concept Laser Gmbh
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Others benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Renishaw plc
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Others benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. ENVISIONTEC US LLC
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Others benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. CELLINK
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Others benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. DETAX Ettlingen
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Others benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Hoganas AB
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Others benchmarking
- 7.3.13.4. Strategic initiatives